Repligen has manufacturing sites in Estonia, Ireland, Netherlands, and Sweden, and is attending conferences in Boston and London.
2 reports, 1 independent
Updated Aug 22
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Repligen has manufacturing sites in Estonia, Ireland, Netherlands, and Sweden, and is attending conferences in Boston and London.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Repligen
bioTech Company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireRepligen Corporation to Present at Upcoming September Conferences WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessin
- GlobeNewswireRepligen to Report Second Quarter 2025 Financial Results Webcast and Conference Call to Be Held Tuesday, July 29, 2025, at 8:30 a.m. ET WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Repligen Corp